© 1996 Oxford University Press
research-article |
Effect of an aqueous extract of selenium-enriched garlic on in vitro markers and in vivo efficacy in cancer prevention
1Division of Laboratory Research, AMC Cancer Research Center 1600 Pierce Street, Denver, CO 80214
2Department of Surgical Oncology, Roswell Park Cancer Institute Buffalo, NY 14263
3Department of Fruit and Vegetable Science, Cornell University Ithaca, NY 14853
4Department of Nutritional Sciences, University of Wisconsin Madison, WI 53706, USA
5To whom correspondence should be addressed
Previous work has shown that the efficacy of cancer prevention by selenium-enriched garlic (Se-garlic) is primarily dependent on the action of selenium. An aqueous extract containing 43 µg Se/ml was prepared from lyophilized Se-garlic powder by the Soxhlet method. The activity of this Se-garlic extract was evaluated in a transformed mammary epithelial cell culture model for its effect on cell morphology, cell growth, cell cycle progression and the induction of single and double stranded breaks in DNA. Comparisons were also made with a similarly prepared extract from regular garlic, Se-methylselenocysteine (a major water-soluble seleno-amino acid identified in Se-garlic) and selenite (used for fertilizing Se-garlic). In contrast to the regular garlic extract which produced little or no modulation of the above parameters, treatment with the Se-garlic extract resulted in growth inhibition, G1 phase cell cycle arrest and apoptotic DNA double strand breaks in the absence of DNA single strand breaks. This pattern of cellular responses was duplicated with exposure to Semethylselenocysteine. Selenite, on the other hand, induced cell cycle blockage in the S/G2-M phase, and a marked increase in DNA single strand breaks (a measure of genotox-icity) in addition to growth suppression. The chemopreven-tive efficacy of the two garlic extracts was also investigated in the rat methylnitrosourea mammary tumor model. Both extracts were supplemented in the diet for 1 month immediately following carcinogen administration. Significant cancer protection was observed with treatment by the Se-garlic extract (at 3 p.p.m. Se in the diet), while little benefit was noted with treatment by the regular garlic extract Based on the above in vitro and in vivo findings, it is hypothesized that the Se-garlic extract, in part via the action of Se-methylselenocysteine, is able to inhibit tumorigenesis by suppressing the proliferation and reducing the survival of the early transformed cells. Furthermore, the data also support the concept that the modulation of certain in vitro markers may be of value in predicting the effectiveness of novel forms of selenium for cancer prevention.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L Alpsoy, G Agar, and M Ikbal Protective role of vitamins A, C, and E against the genotoxic damage induced by aflatoxin B1 in cultured human lymphocytes Toxicology and Industrial Health, April 1, 2009; 25(3): 183 - 188. [Abstract] [PDF]
|
|
|
|
 |
|
 W. Jiang, C. Jiang, H. Pei, L. Wang, J. Zhang, H. Hu, and J. Lu In vivo molecular mediators of cancer growth suppression and apoptosis by selenium in mammary and prostate models: lack of involvement of gadd genes Mol. Cancer Ther., March 1, 2009; 8(3): 682 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhang and H. Zarbl Chemopreventive Doses of Methylselenocysteine Alter Circadian Rhythm in Rat Mammary Tissue Cancer Prevention Research, July 1, 2008; 1(2): 119 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Park, A. Kim, J.-H. Oh, and A.-S. Chung Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-{kappa}B activation Carcinogenesis, April 1, 2007; 28(4): 837 - 847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-S. Keck and J. W. Finley Cruciferous Vegetables: Cancer Protective Mechanisms of Glucosinolate Hydrolysis Products and Selenium Integr Cancer Ther, March 1, 2004; 3(1): 5 - 12. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Kavanaugh and J. E. Green The Use of Genetically Altered Mice for Breast Cancer Prevention Studies J. Nutr., July 1, 2003; 133(7): 2404S - 2409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jiang, Z. Wang, H. Ganther, and J. Lu Distinct Effects of Methylseleninic Acid versus Selenite on Apoptosis, Cell Cycle, and Protein Kinase Pathways in DU145 Human Prostate Cancer Cells Mol. Cancer Ther., October 1, 2002; 1(12): 1059 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zhong and T. D. Oberley Redox-mediated Effects of Selenium on Apoptosis and Cell Cycle in the LNCaP Human Prostate Cancer Cell Line Cancer Res., October 1, 2001; 61(19): 7071 - 7078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jiang, Z. Wang, H. Ganther, and J. Lu Caspases as Key Executors of Methyl Selenium-induced Apoptosis (Anoikis) of DU-145 Prostate Cancer Cells Cancer Res., April 1, 2001; 61(7): 3062 - 3070. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. N. M. Commandeur, I. Andreadou, M. Rooseboom, M. Out, L. J. de Leur, E. Groot, and N. P. E. Vermeulen Bioactivation of Selenocysteine Se-Conjugates by a Highly Purified Rat Renal Cysteine Conjugate beta -Lyase/Glutamine Transaminase K J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 753 - 761. [Abstract] [Full Text]
|
|
|
|
|
|
C. Ip, H. J. Thompson, Z. Zhu, and H. E. Ganther In Vitro and in Vivo Studies of Methylseleninic Acid: Evidence That a Monomethylated Selenium Metabolite Is Critical for Cancer Chemoprevention Cancer Res., June 1, 2000; 60(11): 2882 - 2886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ip, H. J. Thompson, and H. E. Ganther Selenium Modulation of Cell Proliferation and Cell Cycle Biomarkers in Normal and Premalignant Cells of the Rat Mammary Gland Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 49 - 54. [Abstract] [Full Text]
|
|
|
|
|
|
C. Ip Lessons from Basic Research in Selenium and Cancer Prevention J. Nutr., November 1, 1998; 128(11): 1845 - 1854. [Abstract] [Full Text]
|
|